GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD. – Trademark Portfolio

Entity Type: 99

GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include KOLWAY. The owner is based in GUANGZHOU.

703A SELF-COMPILED,ROOM 703,NO.9

LINHE WEST ROAD,TIANHE DISTRICT,

GUANGZHOU , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KOLWAY
KOLWAY
Registered 2024

Trademark Classifications

GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD. have?

GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD. file in?

GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD.'s most well-known trademarks?

GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD.'s registered trademark portfolio includes well-known marks such as KOLWAY. These are among 1 currently registered trademark in the portfolio.

What is GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD.'s trademark registration success rate?

GUANGZHOU AOXIANG MEDICAL TECHNOLOGY CO.,LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.